

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 6.48948475 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 6.41189979 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.67822094 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.67822094 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.67822094 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.67822094 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.67822094 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.67822094 |
| 9 | respiratory burst (GO:0045730) | 5.49414702 |
| 10 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.37301186 |
| 11 | negative regulation of cell killing (GO:0031342) | 5.23170923 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.23170923 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 5.13846675 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.12789007 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.12544931 |
| 16 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.10775171 |
| 17 | superoxide anion generation (GO:0042554) | 4.97982149 |
| 18 | granulocyte activation (GO:0036230) | 4.87526509 |
| 19 | reactive oxygen species biosynthetic process (GO:1903409) | 4.78520610 |
| 20 | neutrophil activation (GO:0042119) | 4.70398722 |
| 21 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.65532279 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.59980230 |
| 23 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.58436759 |
| 24 | leukocyte aggregation (GO:0070486) | 4.46564591 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 4.41859450 |
| 26 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.27357056 |
| 27 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.23630306 |
| 28 | positive regulation of mast cell degranulation (GO:0043306) | 4.23630306 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 4.19764139 |
| 30 | cellular extravasation (GO:0045123) | 4.17572211 |
| 31 | response to host immune response (GO:0052572) | 4.12621069 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.12621069 |
| 33 | detection of bacterium (GO:0016045) | 4.07325504 |
| 34 | regulation of chemokine biosynthetic process (GO:0045073) | 4.01331564 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.99309736 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.96978877 |
| 37 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.96180466 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.93506290 |
| 39 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.87388191 |
| 40 | B cell mediated immunity (GO:0019724) | 3.80779653 |
| 41 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.78322545 |
| 42 | regulation of mast cell degranulation (GO:0043304) | 3.75426889 |
| 43 | regulation of interferon-alpha production (GO:0032647) | 3.74081840 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.70840424 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.70166635 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64847095 |
| 47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.64625395 |
| 48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.64396586 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.62239612 |
| 50 | regulation of mast cell activation (GO:0033003) | 3.61322347 |
| 51 | positive regulation of heat generation (GO:0031652) | 3.60898331 |
| 52 | regulation of fever generation (GO:0031620) | 3.60423712 |
| 53 | response to host (GO:0075136) | 3.59767851 |
| 54 | response to host defenses (GO:0052200) | 3.59767851 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.59767851 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.54890712 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.52021125 |
| 58 | neutrophil chemotaxis (GO:0030593) | 3.50573242 |
| 59 | microglial cell activation (GO:0001774) | 3.48404297 |
| 60 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.48163555 |
| 61 | type I interferon signaling pathway (GO:0060337) | 3.48009954 |
| 62 | cellular response to type I interferon (GO:0071357) | 3.48009954 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.47551601 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.47327532 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.47242521 |
| 66 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.46543267 |
| 67 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46341032 |
| 68 | response to muramyl dipeptide (GO:0032495) | 3.45618775 |
| 69 | response to type I interferon (GO:0034340) | 3.43849047 |
| 70 | germinal center formation (GO:0002467) | 3.42977354 |
| 71 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.41537508 |
| 72 | neutrophil migration (GO:1990266) | 3.40805844 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.40161374 |
| 74 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.37677391 |
| 75 | T-helper 1 type immune response (GO:0042088) | 3.37647594 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 3.36656888 |
| 77 | macrophage activation (GO:0042116) | 3.34749056 |
| 78 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.32278687 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.31699932 |
| 80 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.29946178 |
| 81 | leukocyte mediated cytotoxicity (GO:0001909) | 3.29409943 |
| 82 | negative regulation of interleukin-17 production (GO:0032700) | 3.27934430 |
| 83 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.25177135 |
| 84 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.24511910 |
| 85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.23955573 |
| 86 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22928534 |
| 87 | positive regulation of leukocyte degranulation (GO:0043302) | 3.21377013 |
| 88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20807582 |
| 89 | defense response to protozoan (GO:0042832) | 3.20600847 |
| 90 | regulation of mononuclear cell migration (GO:0071675) | 3.20458156 |
| 91 | response to protozoan (GO:0001562) | 3.20360202 |
| 92 | regulation of tolerance induction (GO:0002643) | 3.19197591 |
| 93 | phagosome maturation (GO:0090382) | 3.18646587 |
| 94 | cellular response to zinc ion (GO:0071294) | 3.18424344 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12983123 |
| 96 | positive regulation of lymphocyte migration (GO:2000403) | 3.12806915 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 3.09846191 |
| 98 | positive regulation of type 2 immune response (GO:0002830) | 3.08614578 |
| 99 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.08068824 |
| 100 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07688829 |
| 101 | regulation of antigen processing and presentation (GO:0002577) | 3.07686994 |
| 102 | detection of other organism (GO:0098543) | 3.06552744 |
| 103 | granulocyte chemotaxis (GO:0071621) | 3.05559699 |
| 104 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.03893475 |
| 105 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03702381 |
| 106 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.02503680 |
| 107 | eosinophil chemotaxis (GO:0048245) | 3.01627154 |
| 108 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.01115583 |
| 109 | detection of external biotic stimulus (GO:0098581) | 3.00888092 |
| 110 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.00723785 |
| 111 | positive regulation of chemokine production (GO:0032722) | 2.99638818 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.99402253 |
| 113 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.99139627 |
| 114 | myeloid dendritic cell differentiation (GO:0043011) | 2.98506268 |
| 115 | eosinophil migration (GO:0072677) | 2.98029370 |
| 116 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.97499010 |
| 117 | granulocyte migration (GO:0097530) | 2.97495049 |
| 118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97205175 |
| 119 | lymphocyte chemotaxis (GO:0048247) | 2.96390327 |
| 120 | positive regulation of interferon-beta production (GO:0032728) | 2.96153727 |
| 121 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.95194835 |
| 122 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.94675107 |
| 123 | positive regulation of interleukin-6 production (GO:0032755) | 2.94600871 |
| 124 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94534371 |
| 125 | myeloid leukocyte activation (GO:0002274) | 2.94051409 |
| 126 | regulation of interleukin-12 production (GO:0032655) | 2.93699591 |
| 127 | myeloid leukocyte mediated immunity (GO:0002444) | 2.93648517 |
| 128 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.92948036 |
| 129 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.84358830 |
| 130 | myeloid dendritic cell activation (GO:0001773) | 2.84310226 |
| 131 | regulation of podosome assembly (GO:0071801) | 2.83530136 |
| 132 | negative regulation of interleukin-6 production (GO:0032715) | 2.80408333 |
| 133 | regulation of type 2 immune response (GO:0002828) | 2.79504846 |
| 134 | positive regulation of interleukin-10 production (GO:0032733) | 2.76633598 |
| 135 | leukocyte degranulation (GO:0043299) | 2.75850107 |
| 136 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.74717413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 9.24325503 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.57215311 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.35674173 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.62715966 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.28514956 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.95815490 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.82271679 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.81201008 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.55082961 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.53198333 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.30069671 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.09703567 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.07524494 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.84550408 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79500699 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70445131 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.58193715 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44665233 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39155333 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.33348918 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21799902 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.96933646 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94333331 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89913078 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81752483 |
| 26 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.80856105 |
| 27 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.77431130 |
| 28 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.75140148 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74441079 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72683540 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.71896813 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68180604 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59399375 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58520258 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57144354 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57057517 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.56316667 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.55718942 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53175397 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48748731 |
| 41 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48360101 |
| 42 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.48178803 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44913777 |
| 44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.44795693 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41719861 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38917926 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38665320 |
| 48 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36991114 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35241987 |
| 50 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34317363 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34004517 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32296317 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31403503 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30554985 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29899948 |
| 56 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29340681 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29097577 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.27624655 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25747135 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23226650 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21677956 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20015162 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19142780 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17074154 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.16745838 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13696062 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13401581 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10907781 |
| 69 | MYB_26560356_Chip-Seq_TH1_Human | 1.09879021 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09765231 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06904589 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04055971 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03536829 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03205150 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02489906 |
| 76 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.02096448 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98710059 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98710059 |
| 79 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.96218806 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93763573 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91851897 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88669086 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88456752 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87417797 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87338775 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84365358 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.83038756 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81561239 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.81344842 |
| 90 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.78647506 |
| 91 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77793455 |
| 92 | UTX_26944678_Chip-Seq_JUKART_Human | 0.77539008 |
| 93 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76436400 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75787966 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75125461 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74785921 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74449801 |
| 98 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.73446979 |
| 99 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73318734 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72540946 |
| 101 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69708625 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.66093530 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65679175 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.64709566 |
| 105 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64110175 |
| 106 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63985165 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.63438690 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.62353319 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61809729 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.61322491 |
| 111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.59929567 |
| 112 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.59103331 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58806920 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.56765172 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.56656747 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.56379284 |
| 117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.55798538 |
| 118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.54603651 |
| 119 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.53857268 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.53411255 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.53411255 |
| 122 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.52939658 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.52541465 |
| 124 | * MAF_26560356_Chip-Seq_TH2_Human | 0.52200937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.68031373 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.46368435 |
| 3 | MP0009785_altered_susceptibility_to | 4.43213775 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 4.01616527 |
| 5 | MP0002419_abnormal_innate_immunity | 3.71438388 |
| 6 | MP0003303_peritoneal_inflammation | 3.66138675 |
| 7 | MP0003724_increased_susceptibility_to | 3.55620601 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.44463142 |
| 9 | MP0005025_abnormal_response_to | 3.34079197 |
| 10 | MP0006082_CNS_inflammation | 3.23612389 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.71232917 |
| 12 | MP0001790_abnormal_immune_system | 2.63685492 |
| 13 | MP0005387_immune_system_phenotype | 2.63685492 |
| 14 | MP0002723_abnormal_immune_serum | 2.56427027 |
| 15 | MP0001800_abnormal_humoral_immune | 2.50894565 |
| 16 | MP0005671_abnormal_response_to | 2.47242764 |
| 17 | MP0000685_abnormal_immune_system | 2.44250556 |
| 18 | MP0009764_decreased_sensitivity_to | 2.38953701 |
| 19 | MP0001533_abnormal_skeleton_physiology | 2.38288680 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.30143053 |
| 21 | MP0001819_abnormal_immune_cell | 2.28966626 |
| 22 | MP0001853_heart_inflammation | 2.28135742 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.25768323 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.23282446 |
| 25 | MP0004510_myositis | 2.20653486 |
| 26 | MP0003075_altered_response_to | 2.13223477 |
| 27 | MP0009278_abnormal_bone_marrow | 2.10543826 |
| 28 | MP0002405_respiratory_system_inflammati | 2.05740778 |
| 29 | MP0001845_abnormal_inflammatory_respons | 2.04356668 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 2.00243714 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.99102177 |
| 32 | MP0000343_altered_response_to | 1.92801449 |
| 33 | MP0002006_tumorigenesis | 1.85148359 |
| 34 | MP0003448_altered_tumor_morphology | 1.84338935 |
| 35 | MP0008469_abnormal_protein_level | 1.83330426 |
| 36 | MP0004947_skin_inflammation | 1.81886110 |
| 37 | MP0000858_altered_metastatic_potential | 1.75263075 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.60508553 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.57877382 |
| 40 | MP0005166_decreased_susceptibility_to | 1.56214123 |
| 41 | MP0000716_abnormal_immune_system | 1.50080189 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.46913014 |
| 43 | MP0003186_abnormal_redox_activity | 1.42192820 |
| 44 | MP0002998_abnormal_bone_remodeling | 1.41987764 |
| 45 | MP0003828_pulmonary_edema | 1.39260889 |
| 46 | MP0005310_abnormal_salivary_gland | 1.37363076 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.34229224 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.34229224 |
| 49 | MP0002277_abnormal_respiratory_mucosa | 1.33166546 |
| 50 | MP0002398_abnormal_bone_marrow | 1.32611728 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.28842600 |
| 52 | MP0008260_abnormal_autophagy | 1.25957025 |
| 53 | MP0000604_amyloidosis | 1.25243963 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.19739029 |
| 55 | MP0005164_abnormal_response_to | 1.19589361 |
| 56 | MP0002429_abnormal_blood_cell | 1.17252192 |
| 57 | MP0003690_abnormal_glial_cell | 1.13346424 |
| 58 | MP0005390_skeleton_phenotype | 1.12167031 |
| 59 | MP0001851_eye_inflammation | 1.11214765 |
| 60 | MP0009763_increased_sensitivity_to | 1.08690200 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.08420390 |
| 62 | MP0003195_calcinosis | 1.06445805 |
| 63 | MP0002933_joint_inflammation | 0.98803731 |
| 64 | MP0002139_abnormal_hepatobiliary_system | 0.96781987 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.96253029 |
| 66 | MP0002722_abnormal_immune_system | 0.96245598 |
| 67 | MP0002254_reproductive_system_inflammat | 0.92913753 |
| 68 | MP0004883_abnormal_blood_vessel | 0.88878217 |
| 69 | MP0006054_spinal_hemorrhage | 0.88789818 |
| 70 | MP0009840_abnormal_foam_cell | 0.83112546 |
| 71 | MP0005076_abnormal_cell_differentiation | 0.83022471 |
| 72 | MP0005451_abnormal_body_composition | 0.82767922 |
| 73 | MP0005174_abnormal_tail_pigmentation | 0.80902617 |
| 74 | MP0000703_abnormal_thymus_morphology | 0.80434695 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 0.78338495 |
| 76 | MP0002166_altered_tumor_susceptibility | 0.76313861 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.75366578 |
| 78 | MP0000920_abnormal_myelination | 0.74740533 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.74631914 |
| 80 | MP0000249_abnormal_blood_vessel | 0.74258564 |
| 81 | MP0003329_amyloid_beta_deposits | 0.72037194 |
| 82 | MP0008874_decreased_physiological_sensi | 0.70573103 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.68509891 |
| 84 | MP0003795_abnormal_bone_structure | 0.66066979 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.62869042 |
| 86 | MP0001873_stomach_inflammation | 0.62147112 |
| 87 | MP0002132_abnormal_respiratory_system | 0.60480114 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 0.59979999 |
| 89 | MP0008873_increased_physiological_sensi | 0.59699251 |
| 90 | MP0004381_abnormal_hair_follicle | 0.58851298 |
| 91 | MP0000371_diluted_coat_color | 0.56713544 |
| 92 | MP0001542_abnormal_bone_strength | 0.56443122 |
| 93 | MP0003091_abnormal_cell_migration | 0.56425566 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.55547480 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.54400060 |
| 96 | MP0003045_fibrosis | 0.53294201 |
| 97 | MP0010307_abnormal_tumor_latency | 0.53168992 |
| 98 | MP0003136_yellow_coat_color | 0.51981569 |
| 99 | MP0003646_muscle_fatigue | 0.51872636 |
| 100 | MP0005535_abnormal_body_temperature | 0.51734183 |
| 101 | MP0000490_abnormal_crypts_of | 0.51572669 |
| 102 | MP0003866_abnormal_defecation | 0.50714802 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.50595146 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 0.50177228 |
| 105 | MP0001663_abnormal_digestive_system | 0.50016193 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.49141634 |
| 107 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49137815 |
| 108 | MP0000609_abnormal_liver_physiology | 0.48593193 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.48284582 |
| 110 | MP0010386_abnormal_urinary_bladder | 0.48003678 |
| 111 | MP0005165_increased_susceptibility_to | 0.46585725 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.45909184 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.41705988 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.41029039 |
| 115 | MP0008004_abnormal_stomach_pH | 0.39916626 |
| 116 | MP0003763_abnormal_thymus_physiology | 0.39695738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 9.18970136 |
| 2 | Eczematoid dermatitis (HP:0000976) | 8.60104711 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 8.27572651 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 8.25708822 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 6.28002730 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.81554532 |
| 7 | Gingivitis (HP:0000230) | 5.30872439 |
| 8 | Stomatitis (HP:0010280) | 5.09442879 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.97887435 |
| 10 | Obstructive lung disease (HP:0006536) | 4.97887435 |
| 11 | Recurrent skin infections (HP:0001581) | 4.97124291 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.59633645 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.25485550 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.12207659 |
| 15 | Recurrent fungal infections (HP:0002841) | 4.11898183 |
| 16 | Myositis (HP:0100614) | 4.11023070 |
| 17 | Orchitis (HP:0100796) | 3.97838900 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.90969591 |
| 19 | Optic neuritis (HP:0100653) | 3.90969591 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.87019224 |
| 21 | Loss of speech (HP:0002371) | 3.55939160 |
| 22 | Urticaria (HP:0001025) | 3.54639006 |
| 23 | Glomerulonephritis (HP:0000099) | 3.43066406 |
| 24 | Vasculitis (HP:0002633) | 3.39680057 |
| 25 | Cellulitis (HP:0100658) | 3.37839125 |
| 26 | Pustule (HP:0200039) | 3.37223658 |
| 27 | Thick nail (HP:0001805) | 3.35500617 |
| 28 | Axonal loss (HP:0003447) | 3.33710846 |
| 29 | Periodontitis (HP:0000704) | 3.32924392 |
| 30 | Prostate neoplasm (HP:0100787) | 3.21003645 |
| 31 | Meningitis (HP:0001287) | 3.18890019 |
| 32 | Increased IgM level (HP:0003496) | 3.18781876 |
| 33 | Recurrent viral infections (HP:0004429) | 3.12642812 |
| 34 | Basal ganglia calcification (HP:0002135) | 3.10596562 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.09095185 |
| 36 | Encephalitis (HP:0002383) | 3.07379524 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.05427221 |
| 38 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.05427221 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.04973342 |
| 40 | Amyloidosis (HP:0011034) | 3.04711418 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 3.00668033 |
| 42 | Recurrent pneumonia (HP:0006532) | 3.00118567 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 2.98201215 |
| 44 | Mutism (HP:0002300) | 2.86120484 |
| 45 | Disinhibition (HP:0000734) | 2.85535799 |
| 46 | Increased IgE level (HP:0003212) | 2.80901053 |
| 47 | T lymphocytopenia (HP:0005403) | 2.73504034 |
| 48 | Pulmonary infiltrates (HP:0002113) | 2.72389185 |
| 49 | Increased serum ferritin (HP:0003281) | 2.67546236 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64326548 |
| 51 | Episodic fever (HP:0001954) | 2.63985567 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61419153 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61419153 |
| 54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61419153 |
| 55 | Agnosia (HP:0010524) | 2.59580734 |
| 56 | Osteomyelitis (HP:0002754) | 2.56544116 |
| 57 | Joint hemorrhage (HP:0005261) | 2.56101724 |
| 58 | Recurrent lower respiratory tract infections (HP:0002783) | 2.51892704 |
| 59 | Chest pain (HP:0100749) | 2.51501026 |
| 60 | Leukocytosis (HP:0001974) | 2.50934225 |
| 61 | Parakeratosis (HP:0001036) | 2.48981044 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.48495324 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.47256502 |
| 64 | Nephritis (HP:0000123) | 2.46000350 |
| 65 | Gingival bleeding (HP:0000225) | 2.45797665 |
| 66 | Pulmonary embolism (HP:0002204) | 2.43852811 |
| 67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.43024622 |
| 68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.43024622 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.43024622 |
| 70 | Hemoptysis (HP:0002105) | 2.37575315 |
| 71 | Petechiae (HP:0000967) | 2.32882489 |
| 72 | Poor head control (HP:0002421) | 2.32637170 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.32532549 |
| 74 | Keratoconjunctivitis sicca (HP:0001097) | 2.30618026 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.30600029 |
| 76 | Hypochromic microcytic anemia (HP:0004840) | 2.29490543 |
| 77 | Polyneuropathy (HP:0001271) | 2.25086195 |
| 78 | Arterial thrombosis (HP:0004420) | 2.25052479 |
| 79 | Premature loss of primary teeth (HP:0006323) | 2.23161227 |
| 80 | Sepsis (HP:0100806) | 2.21330448 |
| 81 | Purpura (HP:0000979) | 2.19676529 |
| 82 | Hypergammaglobulinemia (HP:0010702) | 2.17252813 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.13716406 |
| 84 | Progressive neurologic deterioration (HP:0002344) | 2.10782985 |
| 85 | Hypochromic anemia (HP:0001931) | 2.10462021 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.09612926 |
| 87 | Osteolytic defects of the hand bones (HP:0009699) | 2.09458400 |
| 88 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.09458400 |
| 89 | Vertigo (HP:0002321) | 2.07603767 |
| 90 | Neurofibrillary tangles (HP:0002185) | 2.06578390 |
| 91 | Tetraparesis (HP:0002273) | 2.04586155 |
| 92 | Neuronal loss in central nervous system (HP:0002529) | 2.03881198 |
| 93 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.03214613 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.01720847 |
| 95 | Abnormality of the endocardium (HP:0004306) | 2.01537061 |
| 96 | Myocardial infarction (HP:0001658) | 2.01475158 |
| 97 | Glomerulopathy (HP:0100820) | 2.01375320 |
| 98 | Abnormality of the prostate (HP:0008775) | 2.01230231 |
| 99 | Hematochezia (HP:0002573) | 2.01141036 |
| 100 | Gastrointestinal inflammation (HP:0004386) | 2.00923592 |
| 101 | Skin ulcer (HP:0200042) | 2.00822975 |
| 102 | Acne (HP:0001061) | 2.00692432 |
| 103 | Cheilitis (HP:0100825) | 2.00622637 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00302018 |
| 105 | Abnormality of the pleura (HP:0002103) | 1.98893673 |
| 106 | Inappropriate behavior (HP:0000719) | 1.98693174 |
| 107 | Abnormality of complement system (HP:0005339) | 1.94532338 |
| 108 | Abnormality of T cells (HP:0002843) | 1.93364520 |
| 109 | Nausea (HP:0002018) | 1.93012179 |
| 110 | Epistaxis (HP:0000421) | 1.92641823 |
| 111 | Chronic otitis media (HP:0000389) | 1.92345406 |
| 112 | Memory impairment (HP:0002354) | 1.91227262 |
| 113 | Bone pain (HP:0002653) | 1.88741012 |
| 114 | Anorexia (HP:0002039) | 1.88519010 |
| 115 | Abnormality of the pericardium (HP:0001697) | 1.87582741 |
| 116 | Arthralgia (HP:0002829) | 1.86040539 |
| 117 | Esophageal neoplasm (HP:0100751) | 1.84414734 |
| 118 | Neoplasm of head and neck (HP:0012288) | 1.84414734 |
| 119 | Menorrhagia (HP:0000132) | 1.83222159 |
| 120 | Abnormality of T cell number (HP:0011839) | 1.82613235 |
| 121 | Peritonitis (HP:0002586) | 1.81910904 |
| 122 | Joint swelling (HP:0001386) | 1.79625103 |
| 123 | Pathologic fracture (HP:0002756) | 1.79221644 |
| 124 | Gangrene (HP:0100758) | 1.77292326 |
| 125 | Eosinophilia (HP:0001880) | 1.74934485 |
| 126 | Gastrointestinal stroma tumor (HP:0100723) | 1.72708650 |
| 127 | Upper motor neuron abnormality (HP:0002127) | 1.71761699 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.71210932 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.71122156 |
| 130 | Mucopolysacchariduria (HP:0008155) | 1.71122156 |
| 131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.68970941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.47132267 |
| 2 | BLK | 4.63567235 |
| 3 | MAP3K14 | 4.05507960 |
| 4 | IRAK4 | 3.94622267 |
| 5 | PBK | 3.39990380 |
| 6 | IRAK3 | 3.18275959 |
| 7 | TBK1 | 3.00672387 |
| 8 | MAP4K1 | 2.66133019 |
| 9 | TXK | 2.47753893 |
| 10 | TYK2 | 2.35253631 |
| 11 | IKBKB | 2.32132377 |
| 12 | TAOK1 | 2.17515644 |
| 13 | IKBKE | 2.06400464 |
| 14 | MAP3K3 | 1.99749774 |
| 15 | CSK | 1.98811753 |
| 16 | FGR | 1.87330448 |
| 17 | JAK3 | 1.83202889 |
| 18 | TNK2 | 1.81372207 |
| 19 | TAOK2 | 1.74690715 |
| 20 | PIM2 | 1.67206298 |
| 21 | BMPR2 | 1.58466990 |
| 22 | MST4 | 1.47490832 |
| 23 | KIT | 1.39302302 |
| 24 | HCK | 1.38419426 |
| 25 | YES1 | 1.37673015 |
| 26 | JAK1 | 1.33658311 |
| 27 | ERN1 | 1.31684378 |
| 28 | LYN | 1.31509174 |
| 29 | CLK1 | 1.29266513 |
| 30 | SYK | 1.29139035 |
| 31 | ABL2 | 1.27018485 |
| 32 | ZAP70 | 1.26880632 |
| 33 | TEC | 1.25781532 |
| 34 | BTK | 1.24265961 |
| 35 | MAP3K12 | 1.20710914 |
| 36 | NME2 | 1.17417353 |
| 37 | MAP3K13 | 1.15306637 |
| 38 | STK10 | 1.13689509 |
| 39 | MARK3 | 1.13164988 |
| 40 | RPS6KA4 | 1.12980581 |
| 41 | CSF1R | 1.10013908 |
| 42 | GRK7 | 1.09919865 |
| 43 | CHUK | 1.09049594 |
| 44 | FES | 1.06352660 |
| 45 | CDC42BPA | 1.06256460 |
| 46 | NEK9 | 1.06043228 |
| 47 | PIM1 | 1.05734944 |
| 48 | BMX | 1.05290168 |
| 49 | EIF2AK2 | 1.03908397 |
| 50 | KSR2 | 1.01483657 |
| 51 | MST1R | 0.99632045 |
| 52 | LCK | 0.99321084 |
| 53 | EPHB1 | 0.98405816 |
| 54 | JAK2 | 0.97908476 |
| 55 | TRPM7 | 0.93478266 |
| 56 | MATK | 0.89998586 |
| 57 | PRKCD | 0.89212911 |
| 58 | ERBB3 | 0.89112928 |
| 59 | DDR2 | 0.86461362 |
| 60 | IRAK2 | 0.86047683 |
| 61 | SIK2 | 0.75249470 |
| 62 | MAP3K11 | 0.75044152 |
| 63 | STK4 | 0.74955965 |
| 64 | MARK2 | 0.73389183 |
| 65 | ACVR1B | 0.71478363 |
| 66 | CAMKK2 | 0.71463050 |
| 67 | ABL1 | 0.68180833 |
| 68 | IRAK1 | 0.66562432 |
| 69 | MAP3K5 | 0.64868277 |
| 70 | EIF2AK1 | 0.62805068 |
| 71 | TAOK3 | 0.62008097 |
| 72 | ADRBK2 | 0.61625896 |
| 73 | TGFBR2 | 0.61225887 |
| 74 | MAP2K3 | 0.59952992 |
| 75 | TESK1 | 0.59319830 |
| 76 | PRKD2 | 0.58869816 |
| 77 | EGFR | 0.55704120 |
| 78 | MAP2K6 | 0.52582966 |
| 79 | PRKCQ | 0.50117313 |
| 80 | MAPK7 | 0.47472336 |
| 81 | PTK6 | 0.46612656 |
| 82 | RPS6KC1 | 0.46532359 |
| 83 | RPS6KL1 | 0.46532359 |
| 84 | FYN | 0.44331473 |
| 85 | CDK19 | 0.43214171 |
| 86 | MAPK12 | 0.43187728 |
| 87 | HIPK2 | 0.43160780 |
| 88 | ITK | 0.43011546 |
| 89 | EPHA3 | 0.42466340 |
| 90 | MAP3K6 | 0.42113052 |
| 91 | KSR1 | 0.40741488 |
| 92 | LRRK2 | 0.40244798 |
| 93 | DYRK1B | 0.38833846 |
| 94 | EIF2AK3 | 0.38071867 |
| 95 | DYRK3 | 0.37467274 |
| 96 | PDPK1 | 0.36786851 |
| 97 | FGFR3 | 0.36396403 |
| 98 | PIK3CG | 0.36185477 |
| 99 | CAMK1D | 0.35905997 |
| 100 | RIPK1 | 0.34415586 |
| 101 | STK3 | 0.34372430 |
| 102 | DAPK3 | 0.34202510 |
| 103 | BMPR1B | 0.34180141 |
| 104 | SIK1 | 0.33778452 |
| 105 | ARAF | 0.33741601 |
| 106 | PDK1 | 0.33686347 |
| 107 | SGK3 | 0.33320193 |
| 108 | MOS | 0.33133859 |
| 109 | ADRBK1 | 0.32774866 |
| 110 | MAPKAPK2 | 0.32709303 |
| 111 | SIK3 | 0.32623926 |
| 112 | ERBB4 | 0.32196850 |
| 113 | STK11 | 0.30789907 |
| 114 | TRIB3 | 0.30583201 |
| 115 | MAP2K4 | 0.30027101 |
| 116 | GRK6 | 0.28895043 |
| 117 | DMPK | 0.25751535 |
| 118 | RPS6KA6 | 0.25733742 |
| 119 | CAMKK1 | 0.25552336 |
| 120 | TLK1 | 0.25116121 |
| 121 | RPS6KA2 | 0.23680227 |
| 122 | IGF1R | 0.22693308 |
| 123 | PRKG2 | 0.21049330 |
| 124 | DAPK2 | 0.20456066 |
| 125 | MAP3K1 | 0.19558914 |
| 126 | TTN | 0.19087339 |
| 127 | INSR | 0.17255008 |
| 128 | PRKCH | 0.16805322 |
| 129 | GRK5 | 0.16715517 |
| 130 | PRPF4B | 0.15871987 |
| 131 | MUSK | 0.13720765 |
| 132 | MAPK4 | 0.13550885 |
| 133 | TESK2 | 0.13502422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.98250369 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.97146963 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.83231764 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 3.14414066 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.78289928 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.69075329 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63636222 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.56859610 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53503782 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.51367137 |
| 11 | Malaria_Homo sapiens_hsa05144 | 2.46263287 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.46161306 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 2.44652824 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42926993 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.36741940 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33157627 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 2.25283131 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24759415 |
| 19 | Phagosome_Homo sapiens_hsa04145 | 1.97250041 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96318614 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.84674358 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.81247002 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.78115099 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76936427 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.59236462 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54559624 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.54270089 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49906863 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48659394 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46970712 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36344887 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36037518 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31051483 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.24563247 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23956321 |
| 36 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.20092920 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17034511 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.12299252 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06689166 |
| 40 | Amoebiasis_Homo sapiens_hsa05146 | 1.04220777 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02936989 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00108055 |
| 43 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99313963 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98886200 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98390798 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 0.97602798 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91477138 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.90664549 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87434288 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84207999 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82616772 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80739738 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.78197270 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76038351 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70702063 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68402687 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63002579 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61157974 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59207004 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57469074 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.55706660 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.52709883 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51559444 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48212394 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.47386136 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46845081 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46836758 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45220706 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44994872 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43336738 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42817354 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42635664 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42621754 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41301663 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40337815 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39326196 |
| 77 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38188981 |
| 78 | Proteasome_Homo sapiens_hsa03050 | 0.37842242 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36035310 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35764894 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32698157 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31318788 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31181492 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30136375 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29879589 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.27905763 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26844612 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26260639 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26017555 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25542087 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24958455 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.24648242 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23781827 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21508318 |
| 95 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.21103525 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20760482 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20356172 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19748864 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19623876 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.17929924 |
| 101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.16385121 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15741668 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14832477 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14659662 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.14501636 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.12616699 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11657315 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.11393465 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09009462 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07265086 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05991799 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.04761756 |
| 113 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03430830 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.02644055 |

